| |
Institute
of Pathology (AH, UR, GS, WD, FH, RK) and Center of Molecular Diagnostics
(WD), University of Regensburg, Regensburg; and Department of Urology (DZ),
Ludwig Maximilian University, Munich, Germany |
| |
SUMMARY:
Multifocality and recurrence are clinically important features of
urothelial carcinomas of the urinary bladder. Recent molecular genetic
studies have suggested that multifocal urothelial carcinomas are monoclonally
derived from an identical transformed progenitor cell. However, most of
these studies investigated advanced and poorly differentiated tumors.
The study presented focuses on early papillary tumors, including 52 superficial
well-differentiated multifocal and recurrent bladder carcinomas from 10
patients. Microdissection separating urothelium from stromal cells was
considered essential to obtain pure tumor cell populations. Genetic analysis
was carried out by applying two different methods. Dual color fluorescence
in situ hybridization (FISH) with centromeric probes for chromosomes 9
and 17 and gene-specific probes for chromosome loci 9q22, 9p21, and 17p13
was carried out in parallel to loss of heterozygosity (LOH) analyses applying
5 microsatellite markers on these chromosomes. Overall, deletions on chromosome
9p were found in 47 tumors (90%), at chromosome 9q in 36 tumors (69%)
and at chromosome 17p in 3 tumors (6%). There was a very high correlation
of the results between FISH and LOH analysis. Ten early superficial papillary
tumors showed deletion of chromosome 9p without deletion of 9q, suggesting
9p deletions as a very early event in the development of papillary urothelial
carcinoma. Although in four patients, all investigated tumors showed identical
genetic alterations and one patient showed no genetic alterations at the
loci investigated, in five patients, two or more clones with different
deletions were found. In four of these patients, the results are compatible
with clonal divergence and selection of different cell subpopulations
derived from a common progenitor cell. However, in one patient different
alleles in two markers at chromosome 9 were deleted, favoring an independent
evolution of two recurring tumor cell clones. In summary, we could show
that there is considerable genetic heterogeneity in early multifocal and
recurring urothelial carcinoma and demonstrated the occurrence of two
independent clones in at least one patient as an indicator of possible
initial oligoclonality of bladder cancer.
|